3001 - 3010 of 6515 Results
Title
Year
-
OPENTitle: Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in miceJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 18Start Page: 2008End Page: 2025Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.201593585Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5282834Citation Count: 64
-
OPENTitle: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patientsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abg3092Best OA location URL: https://doi.org/10.1126/sciadv.abg3092Citation Count: 91
-
OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 9
-
OPENTitle: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase InhibitorsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 18Issue #: 4Start Page: 810End Page: 821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.2c00868Best OA location URL: https://doi.org/10.1021/acschembio.2c00868Citation Count: 13
-
OPENTitle: Digital health technology for Parkinson's disease with comprehensive monitoring and artificial intelligence-enabled haptic biofeedback for bulbar dysfunctionJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251329354Best OA location URL: https://doi.org/10.1177/1877718x251329354Citation Count: 0
-
OPENTitle: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6357Start Page: 1255End Page: 1261Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aam9080Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6021018Citation Count: 736
-
OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 0
-
OPENTitle: Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 61Issue #: 1Start Page: 228End Page: 239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2012.02.066Best OA location URL: http://doi.org/10.1016/j.neuroimage.2012.02.066Citation Count: 71
-
OPENTitle: A novel class of negative allosteric modulators of NMDA receptor functionJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 25Issue #: 23Start Page: 5583End Page: 5588Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2015.10.046Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7971076Citation Count: 15
-
OPENTitle: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdfCitation Count: 26